Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Prostate Cancer Metastatic × Dexamethasone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 136 Precursor Cell Lymphoblastic Leukemia-Lymphoma 31 Vomiting 22 Recurrence 21 Leukemia 20 Neoplasms, Plasma Cell 17 Neoplasms 16 Nausea 12 Lymphoma 12 Prostatic Neoplasms 8 Burkitt Lymphoma 7 Immunoglobulin Light-chain Amyloidosis 6 Carcinoma, Non-Small-Cell Lung 6 Lung Neoplasms 5 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Lymphoma, Follicular 4 Hodgkin Disease 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Small Cell Lung Carcinoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Paraproteinemias 3 Lymphoma, Non-Hodgkin 3 Fallopian Tube Neoplasms 3 Smoldering Multiple Myeloma 2 Plasmacytoma 2 Lymphoproliferative Disorders 2 Lymphoma, Mantle-Cell 2

Interventions

enzalutamide 2 cabazitaxel 2 Prednisone 2 Androgen Antagonists 2 fludrocortisone acetate 1 darolutamide 1 XRP6258 1 Radiosurgery 1 Pluvicto 1 Lutetium-177 1 Lutetium 1 Lenograstim 1 Hydrocortisone 1 Granulocyte Colony-Stimulating Factor 1 Docetaxel 1 Dexamethasone 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06136624 2026-03-11

OMAHA-003

Merck Sharp & Dohme LLC

Phase 3 Recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡